A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

BACKGROUND: Although sentinel lymph node biopsy (SLNB) status is a strong prognostic indicator for cutaneous melanoma, unnecessary SLNBs have substantial cost and morbidity burden. OBJECTIVE: This study was designed to develop, validate, and present a personalized, clinical, decision-making tool usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Raghav, Larson, Karen, Fowler, Graham, Han, Dale, Vetto, John T., Bordeaux, Jeremy S., Yu, Wesley Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Melanoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961302/
https://www.ncbi.nlm.nih.gov/pubmed/36840860
http://dx.doi.org/10.1245/s10434-023-13220-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961302/
https://www.ncbi.nlm.nih.gov/pubmed/36840860
http://dx.doi.org/10.1245/s10434-023-13220-0

Ejemplares similares